SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification

Published On 2025-05-02 06:00 GMT   |   Update On 2025-05-02 06:00 GMT
Advertisement

Telangana: SMS Pharmaceuticals Limited has informed in a BSE filing that the company's Unit VII manufacturing facility in Visakhapatnam, Andhra Pradesh, has received prequalification approval from the World Health Organisation (WHO) Geneva.

"This significant milestone enhances our global regulatory standing and enables the company to increase its presence in the global market for Anti-Retroviral (ARV) APIs," SMS Pharma said.

Advertisement

Commenting on this achievement, P. Vamsi Krishna, Executive Director, stated, “The WHO Geneva prequalification reflects the company’s strong compliance with stringent international regulatory standards, reinforcing its reputation for quality, reliability, and global competitiveness."

Read also: Strides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drug

Established in 1990, SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company specialising in API and intermediatesfor global customers. The Company operates two state-of-the-art manufacturing facilities in Hyderabad and Vizag, with capacities of 120 KL and 3,000 KL, respectively.

Read also: SMS Pharma gets one USFDA observation for Bachupally facility



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News